In summary, we performed an integrative analysis of multi-omics in AML and identified the differential DNA methylated genes such as CD34, HOXA7, and CD96 and explored DNA methylation and clinical implication of CD34, HOXA7, and CD96 in AML. This evidence concerns the gene CD34 and acute myeloid leukemia.